Global and United States Devices for Inhaled Medications Market Insights, Forecast to 2026

Global and United States Devices for Inhaled Medications Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Devices for Inhaled Medications Product Introduction
1.2 Market Segments
1.3 Key Devices for Inhaled Medications Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Devices for Inhaled Medications Market Size Growth Rate by Type
1.4.2 Dry Powder Inhalers
1.4.3 Metered-Dose Inhalers
1.4.4 Nebulizers
1.4.5 Soft Mist Inhaler
1.5 Market by Application
1.5.1 Global Devices for Inhaled Medications Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Home
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Devices for Inhaled Medications Market Size, Estimates and Forecasts
2.1.1 Global Devices for Inhaled Medications Revenue 2015-2026
2.1.2 Global Devices for Inhaled Medications Sales 2015-2026
2.2 Global Devices for Inhaled Medications, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Devices for Inhaled Medications Historical Market Size by Region (2015-2020)
2.3.1 Global Devices for Inhaled Medications Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Devices for Inhaled Medications Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Devices for Inhaled Medications Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Devices for Inhaled Medications Sales Forecast by Region (2021-2026)
2.4.2 Global Devices for Inhaled Medications Revenue Forecast by Region (2021-2026)
3 Global Devices for Inhaled Medications Competitor Landscape by Players
3.1 Global Top Devices for Inhaled Medications Sales by Manufacturers
3.1.1 Global Devices for Inhaled Medications Sales by Manufacturers (2015-2020)
3.1.2 Global Devices for Inhaled Medications Sales Market Share by Manufacturers (2015-2020)
3.2 Global Devices for Inhaled Medications Manufacturers by Revenue
3.2.1 Global Devices for Inhaled Medications Revenue by Manufacturers (2015-2020)
3.2.2 Global Devices for Inhaled Medications Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Devices for Inhaled Medications Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Devices for Inhaled Medications Revenue in 2019
3.2.5 Global Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Devices for Inhaled Medications Price by Manufacturers
3.4 Global Devices for Inhaled Medications Manufacturing Base Distribution, Product Types
3.4.1 Devices for Inhaled Medications Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Devices for Inhaled Medications Product Type
3.4.3 Date of International Manufacturers Enter into Devices for Inhaled Medications Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Devices for Inhaled Medications Market Size by Type (2015-2020)
4.1.1 Global Devices for Inhaled Medications Sales by Type (2015-2020)
4.1.2 Global Devices for Inhaled Medications Revenue by Type (2015-2020)
4.1.3 Devices for Inhaled Medications Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Devices for Inhaled Medications Market Size Forecast by Type (2021-2026)
4.2.1 Global Devices for Inhaled Medications Sales Forecast by Type (2021-2026)
4.2.2 Global Devices for Inhaled Medications Revenue Forecast by Type (2021-2026)
4.2.3 Devices for Inhaled Medications Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Devices for Inhaled Medications Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Devices for Inhaled Medications Market Size by Application (2015-2020)
5.1.1 Global Devices for Inhaled Medications Sales by Application (2015-2020)
5.1.2 Global Devices for Inhaled Medications Revenue by Application (2015-2020)
5.1.3 Devices for Inhaled Medications Price by Application (2015-2020)
5.2 Devices for Inhaled Medications Market Size Forecast by Application (2021-2026)
5.2.1 Global Devices for Inhaled Medications Sales Forecast by Application (2021-2026)
5.2.2 Global Devices for Inhaled Medications Revenue Forecast by Application (2021-2026)
5.2.3 Global Devices for Inhaled Medications Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Devices for Inhaled Medications Market Size YoY Growth 2015-2026
6.1.1 United States Devices for Inhaled Medications Sales YoY Growth 2015-2026
6.1.2 United States Devices for Inhaled Medications Revenue YoY Growth 2015-2026
6.1.3 United States Devices for Inhaled Medications Market Share in Global Market 2015-2026
6.2 United States Devices for Inhaled Medications Market Size by Players (International and Local Players)
6.2.1 United States Top Devices for Inhaled Medications Players by Sales (2015-2020)
6.2.2 United States Top Devices for Inhaled Medications Players by Revenue (2015-2020)
6.3 United States Devices for Inhaled Medications Historic Market Review by Type (2015-2020)
6.3.1 United States Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
6.3.2 United States Devices for Inhaled Medications Revenue Market Share by Type (2015-2020)
6.3.3 United States Devices for Inhaled Medications Price by Type (2015-2020)
6.4 United States Devices for Inhaled Medications Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Devices for Inhaled Medications Sales Forecast by Type (2021-2026)
6.4.2 United States Devices for Inhaled Medications Revenue Forecast by Type (2021-2026)
6.4.3 United States Devices for Inhaled Medications Price Forecast by Type (2021-2026)
6.5 United States Devices for Inhaled Medications Historic Market Review by Application (2015-2020)
6.5.1 United States Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
6.5.2 United States Devices for Inhaled Medications Revenue Market Share by Application (2015-2020)
6.5.3 United States Devices for Inhaled Medications Price by Application (2015-2020)
6.6 United States Devices for Inhaled Medications Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Devices for Inhaled Medications Sales Forecast by Application (2021-2026)
6.6.2 United States Devices for Inhaled Medications Revenue Forecast by Application (2021-2026)
6.6.3 United States Devices for Inhaled Medications Price Forecast by Application (2021-2026)
7 North America
7.1 North America Devices for Inhaled Medications Market Size YoY Growth 2015-2026
7.2 North America Devices for Inhaled Medications Market Facts & Figures by Country
7.2.1 North America Devices for Inhaled Medications Sales by Country (2015-2020)
7.2.2 North America Devices for Inhaled Medications Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Devices for Inhaled Medications Market Size YoY Growth 2015-2026
8.2 Europe Devices for Inhaled Medications Market Facts & Figures by Country
8.2.1 Europe Devices for Inhaled Medications Sales by Country
8.2.2 Europe Devices for Inhaled Medications Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Devices for Inhaled Medications Market Size YoY Growth 2015-2026
9.2 Asia Pacific Devices for Inhaled Medications Market Facts & Figures by Country
9.2.1 Asia Pacific Devices for Inhaled Medications Sales by Region (2015-2020)
9.2.2 Asia Pacific Devices for Inhaled Medications Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Devices for Inhaled Medications Market Size YoY Growth 2015-2026
10.2 Latin America Devices for Inhaled Medications Market Facts & Figures by Country
10.2.1 Latin America Devices for Inhaled Medications Sales by Country
10.2.2 Latin America Devices for Inhaled Medications Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Devices for Inhaled Medications Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Devices for Inhaled Medications Market Facts & Figures by Country
11.2.1 Middle East and Africa Devices for Inhaled Medications Sales by Country
11.2.2 Middle East and Africa Devices for Inhaled Medications Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Consort Medical
12.1.1 Consort Medical Corporation Information
12.1.2 Consort Medical Description and Business Overview
12.1.3 Consort Medical Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Consort Medical Devices for Inhaled Medications Products Offered
12.1.5 Consort Medical Recent Development
12.2 Inhalexper
12.2.1 Inhalexper Corporation Information
12.2.2 Inhalexper Description and Business Overview
12.2.3 Inhalexper Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Inhalexper Devices for Inhaled Medications Products Offered
12.2.5 Inhalexper Recent Development
12.3 Cambridge Consultants
12.3.1 Cambridge Consultants Corporation Information
12.3.2 Cambridge Consultants Description and Business Overview
12.3.3 Cambridge Consultants Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Cambridge Consultants Devices for Inhaled Medications Products Offered
12.3.5 Cambridge Consultants Recent Development
12.4 Hovione
12.4.1 Hovione Corporation Information
12.4.2 Hovione Description and Business Overview
12.4.3 Hovione Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Hovione Devices for Inhaled Medications Products Offered
12.4.5 Hovione Recent Development
12.5 Catalent, Inc
12.5.1 Catalent, Inc Corporation Information
12.5.2 Catalent, Inc Description and Business Overview
12.5.3 Catalent, Inc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Catalent, Inc Devices for Inhaled Medications Products Offered
12.5.5 Catalent, Inc Recent Development
12.6 VertMarkets, Inc
12.6.1 VertMarkets, Inc Corporation Information
12.6.2 VertMarkets, Inc Description and Business Overview
12.6.3 VertMarkets, Inc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 VertMarkets, Inc Devices for Inhaled Medications Products Offered
12.6.5 VertMarkets, Inc Recent Development
12.7 Qualicaps
12.7.1 Qualicaps Corporation Information
12.7.2 Qualicaps Description and Business Overview
12.7.3 Qualicaps Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Qualicaps Devices for Inhaled Medications Products Offered
12.7.5 Qualicaps Recent Development
12.8 3M
12.8.1 3M Corporation Information
12.8.2 3M Description and Business Overview
12.8.3 3M Sales, Revenue and Gross Margin (2015-2020)
12.8.4 3M Devices for Inhaled Medications Products Offered
12.8.5 3M Recent Development
12.9 Aerovance
12.9.1 Aerovance Corporation Information
12.9.2 Aerovance Description and Business Overview
12.9.3 Aerovance Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Aerovance Devices for Inhaled Medications Products Offered
12.9.5 Aerovance Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Corporation Information
12.10.2 AstraZeneca Description and Business Overview
12.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AstraZeneca Devices for Inhaled Medications Products Offered
12.10.5 AstraZeneca Recent Development
12.11 Consort Medical
12.11.1 Consort Medical Corporation Information
12.11.2 Consort Medical Description and Business Overview
12.11.3 Consort Medical Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Consort Medical Devices for Inhaled Medications Products Offered
12.11.5 Consort Medical Recent Development
12.12 Chiesi
12.12.1 Chiesi Corporation Information
12.12.2 Chiesi Description and Business Overview
12.12.3 Chiesi Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Chiesi Products Offered
12.12.5 Chiesi Recent Development
12.13 Cipla
12.13.1 Cipla Corporation Information
12.13.2 Cipla Description and Business Overview
12.13.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Cipla Products Offered
12.13.5 Cipla Recent Development
12.14 Civitas/Alkermes
12.14.1 Civitas/Alkermes Corporation Information
12.14.2 Civitas/Alkermes Description and Business Overview
12.14.3 Civitas/Alkermes Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Civitas/Alkermes Products Offered
12.14.5 Civitas/Alkermes Recent Development
12.15 GlaxoSmithKline
12.15.1 GlaxoSmithKline Corporation Information
12.15.2 GlaxoSmithKline Description and Business Overview
12.15.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.15.4 GlaxoSmithKline Products Offered
12.15.5 GlaxoSmithKline Recent Development
12.16 Hovione
12.16.1 Hovione Corporation Information
12.16.2 Hovione Description and Business Overview
12.16.3 Hovione Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Hovione Products Offered
12.16.5 Hovione Recent Development
12.17 Mannkind
12.17.1 Mannkind Corporation Information
12.17.2 Mannkind Description and Business Overview
12.17.3 Mannkind Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Mannkind Products Offered
12.17.5 Mannkind Recent Development
12.18 Mantecorp
12.18.1 Mantecorp Corporation Information
12.18.2 Mantecorp Description and Business Overview
12.18.3 Mantecorp Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Mantecorp Products Offered
12.18.5 Mantecorp Recent Development
12.19 Meda
12.19.1 Meda Corporation Information
12.19.2 Meda Description and Business Overview
12.19.3 Meda Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Meda Products Offered
12.19.5 Meda Recent Development
12.20 MicroDose Therapeutx
12.20.1 MicroDose Therapeutx Corporation Information
12.20.2 MicroDose Therapeutx Description and Business Overview
12.20.3 MicroDose Therapeutx Sales, Revenue and Gross Margin (2015-2020)
12.20.4 MicroDose Therapeutx Products Offered
12.20.5 MicroDose Therapeutx Recent Development
12.21 Novartis
12.21.1 Novartis Corporation Information
12.21.2 Novartis Description and Business Overview
12.21.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Novartis Products Offered
12.21.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Devices for Inhaled Medications Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Devices for Inhaled Medications Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Devices for Inhaled Medications Market Segments
Table 2. Ranking of Global Top Devices for Inhaled Medications Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Devices for Inhaled Medications Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Dry Powder Inhalers
Table 5. Major Manufacturers of Metered-Dose Inhalers
Table 6. Major Manufacturers of Nebulizers
Table 7. Major Manufacturers of Soft Mist Inhaler
Table 8. Global Devices for Inhaled Medications Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Devices for Inhaled Medications Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Devices for Inhaled Medications Sales by Regions 2015-2020 (K Units)
Table 11. Global Devices for Inhaled Medications Sales Market Share by Regions (2015-2020)
Table 12. Global Devices for Inhaled Medications Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Devices for Inhaled Medications Sales Forecast by Region (2021-2026) (K Units)
Table 14. Global Devices for Inhaled Medications Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Devices for Inhaled Medications Sales Share by Manufacturers (2015-2020)
Table 16. Global Devices for Inhaled Medications Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Devices for Inhaled Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Devices for Inhaled Medications as of 2019)
Table 18. Devices for Inhaled Medications Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Devices for Inhaled Medications Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Devices for Inhaled Medications Price (2015-2020) (USD/Unit)
Table 21. Devices for Inhaled Medications Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Devices for Inhaled Medications Product Type
Table 23. Date of International Manufacturers Enter into Devices for Inhaled Medications Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Devices for Inhaled Medications Sales by Type (2015-2020) (K Units)
Table 26. Global Devices for Inhaled Medications Sales Share by Type (2015-2020)
Table 27. Global Devices for Inhaled Medications Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Devices for Inhaled Medications Revenue Share by Type (2015-2020)
Table 29. Devices for Inhaled Medications Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Devices for Inhaled Medications Sales Share by Type (2021-2026)
Table 31. Global Devices for Inhaled Medications Sales by Application (2015-2020) (K Units)
Table 32. Global Devices for Inhaled Medications Sales Share by Application (2015-2020)
Table 33. Global Devices for Inhaled Medications Sales Share by Application (2021-2026)
Table 34. Global Devices for Inhaled Medications Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Devices for Inhaled Medications Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Devices for Inhaled Medications Revenue Market Share Forecast by Application (2021-2026)
Table 37. United States Devices for Inhaled Medications Sales (K Units) of Key Companies (2015-2020)
Table 38. United States Devices for Inhaled Medications Sales Share by Company (2015-2020)
Table 39. United States Devices for Inhaled Medications Revenue (US$ Million) by Company (2015-2020)
Table 40. United States Devices for Inhaled Medications Sales (K Units) by Type (2015-2020)
Table 41. United States Devices for Inhaled Medications Sales Share by Type (2015-2020)
Table 42. United States Devices for Inhaled Medications Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. United States Devices for Inhaled Medications Price (K Units) by Type (2015-2020)
Table 44. United States Devices for Inhaled Medications Sales (K Units) by Type (2021-2026)
Table 45. United States Devices for Inhaled Medications Sales Share by Type (2021-2026)
Table 46. United States Devices for Inhaled Medications Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. United States Devices for Inhaled Medications Revenue Share by Type (2021-2026)
Table 48. United States Devices for Inhaled Medications Price (K Units) by Type (2021-2026)
Table 49. United States Devices for Inhaled Medications Sales (K Units) by Application (2015-2020)
Table 50. United States Devices for Inhaled Medications Sales Share by Application (2015-2020)
Table 51. United States Devices for Inhaled Medications Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. United States Devices for Inhaled Medications Sales (K Units) by Application (2021-2026)
Table 53. United States Devices for Inhaled Medications Sales Share by Application (2021-2026)
Table 54. United States Devices for Inhaled Medications Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. United States Devices for Inhaled Medications Revenue Share by Application (2021-2026)
Table 56. North America Devices for Inhaled Medications Sales by Country (2015-2020) (K Units)
Table 57. North America Devices for Inhaled Medications Sales Market Share by Country (2015-2020)
Table 58. North America Devices for Inhaled Medications Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Devices for Inhaled Medications Revenue Market Share by Country (2015-2020)
Table 60. Europe Devices for Inhaled Medications Sales by Country (2015-2020) (K Units)
Table 61. Europe Devices for Inhaled Medications Sales Market Share by Country (2015-2020)
Table 62. Europe Devices for Inhaled Medications Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Devices for Inhaled Medications Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Devices for Inhaled Medications Sales by Region (2015-2020) (K Units)
Table 65. Asia Pacific Devices for Inhaled Medications Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Devices for Inhaled Medications Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Devices for Inhaled Medications Revenue Market Share by Region (2015-2020)
Table 68. Latin America Devices for Inhaled Medications Sales by Country (2015-2020) (K Units)
Table 69. Latin America Devices for Inhaled Medications Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Devices for Inhaled Medications Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Devices for Inhaled Medications Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Devices for Inhaled Medications Sales by Country (2015-2020) (K Units)
Table 73. Middle East and Africa Devices for Inhaled Medications Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Devices for Inhaled Medications Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Devices for Inhaled Medications Revenue Market Share by Country (2015-2020)
Table 76. Consort Medical Corporation Information
Table 77. Consort Medical Description and Business Overview
Table 78. Consort Medical Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Consort Medical Devices for Inhaled Medications Product
Table 80. Consort Medical Recent Development
Table 81. Inhalexper Corporation Information
Table 82. Inhalexper Description and Business Overview
Table 83. Inhalexper Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Inhalexper Product
Table 85. Inhalexper Recent Development
Table 86. Cambridge Consultants Corporation Information
Table 87. Cambridge Consultants Description and Business Overview
Table 88. Cambridge Consultants Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Cambridge Consultants Product
Table 90. Cambridge Consultants Recent Development
Table 91. Hovione Corporation Information
Table 92. Hovione Description and Business Overview
Table 93. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Hovione Product
Table 95. Hovione Recent Development
Table 96. Catalent, Inc Corporation Information
Table 97. Catalent, Inc Description and Business Overview
Table 98. Catalent, Inc Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Catalent, Inc Product
Table 100. Catalent, Inc Recent Development
Table 101. VertMarkets, Inc Corporation Information
Table 102. VertMarkets, Inc Description and Business Overview
Table 103. VertMarkets, Inc Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. VertMarkets, Inc Product
Table 105. VertMarkets, Inc Recent Development
Table 106. Qualicaps Corporation Information
Table 107. Qualicaps Description and Business Overview
Table 108. Qualicaps Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Qualicaps Product
Table 110. Qualicaps Recent Development
Table 111. 3M Corporation Information
Table 112. 3M Description and Business Overview
Table 113. 3M Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. 3M Product
Table 115. 3M Recent Development
Table 116. Aerovance Corporation Information
Table 117. Aerovance Description and Business Overview
Table 118. Aerovance Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Aerovance Product
Table 120. Aerovance Recent Development
Table 121. AstraZeneca Corporation Information
Table 122. AstraZeneca Description and Business Overview
Table 123. AstraZeneca Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. AstraZeneca Product
Table 125. AstraZeneca Recent Development
Table 126. Boehringer Ingelheim Corporation Information
Table 127. Boehringer Ingelheim Description and Business Overview
Table 128. Boehringer Ingelheim Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Boehringer Ingelheim Product
Table 130. Boehringer Ingelheim Recent Development
Table 131. Chiesi Corporation Information
Table 132. Chiesi Description and Business Overview
Table 133. Chiesi Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Chiesi Product
Table 135. Chiesi Recent Development
Table 136. Cipla Corporation Information
Table 137. Cipla Description and Business Overview
Table 138. Cipla Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Cipla Product
Table 140. Cipla Recent Development
Table 141. Civitas/Alkermes Corporation Information
Table 142. Civitas/Alkermes Description and Business Overview
Table 143. Civitas/Alkermes Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 144. Civitas/Alkermes Product
Table 145. Civitas/Alkermes Recent Development
Table 146. GlaxoSmithKline Corporation Information
Table 147. GlaxoSmithKline Description and Business Overview
Table 148. GlaxoSmithKline Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 149. GlaxoSmithKline Product
Table 150. GlaxoSmithKline Recent Development
Table 151. Hovione Corporation Information
Table 152. Hovione Description and Business Overview
Table 153. Hovione Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 154. Hovione Product
Table 155. Hovione Recent Development
Table 156. Mannkind Corporation Information
Table 157. Mannkind Description and Business Overview
Table 158. Mannkind Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 159. Mannkind Product
Table 160. Mannkind Recent Development
Table 161. Mantecorp Corporation Information
Table 162. Mantecorp Description and Business Overview
Table 163. Mantecorp Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 164. Mantecorp Product
Table 165. Mantecorp Recent Development
Table 166. Meda Corporation Information
Table 167. Meda Description and Business Overview
Table 168. Meda Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 169. Meda Product
Table 170. Meda Recent Development
Table 171. MicroDose Therapeutx Corporation Information
Table 172. MicroDose Therapeutx Description and Business Overview
Table 173. MicroDose Therapeutx Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 174. MicroDose Therapeutx Product
Table 175. MicroDose Therapeutx Recent Development
Table 176. Novartis Corporation Information
Table 177. Novartis Description and Business Overview
Table 178. Novartis Devices for Inhaled Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 179. Novartis Product
Table 180. Novartis Recent Development
Table 181. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 182. Key Challenges
Table 183. Market Risks
Table 184. Main Points Interviewed from Key Devices for Inhaled Medications Players
Table 185. Devices for Inhaled Medications Customers List
Table 186. Devices for Inhaled Medications Distributors List
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Devices for Inhaled Medications Product Picture
Figure 2. Global Devices for Inhaled Medications Sales Market Share by Type in 2020 & 2026
Figure 3. Dry Powder Inhalers Product Picture
Figure 4. Metered-Dose Inhalers Product Picture
Figure 5. Nebulizers Product Picture
Figure 6. Soft Mist Inhaler Product Picture
Figure 7. Global Devices for Inhaled Medications Sales Market Share by Application in 2020 & 2026
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Home
Figure 11. Devices for Inhaled Medications Report Years Considered
Figure 12. Global Devices for Inhaled Medications Market Size 2015-2026 (US$ Million)
Figure 13. Global Devices for Inhaled Medications Sales 2015-2026 (K Units)
Figure 14. Global Devices for Inhaled Medications Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Devices for Inhaled Medications Sales Market Share by Region (2015-2020)
Figure 16. Global Devices for Inhaled Medications Sales Market Share by Region in 2019
Figure 17. Global Devices for Inhaled Medications Revenue Market Share by Region (2015-2020)
Figure 18. Global Devices for Inhaled Medications Revenue Market Share by Region in 2019
Figure 19. Global Devices for Inhaled Medications Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Devices for Inhaled Medications Revenue in 2019
Figure 21. Devices for Inhaled Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Devices for Inhaled Medications Sales Market Share by Type (2015-2020)
Figure 23. Global Devices for Inhaled Medications Sales Market Share by Type in 2019
Figure 24. Global Devices for Inhaled Medications Revenue Market Share by Type (2015-2020)
Figure 25. Global Devices for Inhaled Medications Revenue Market Share by Type in 2019
Figure 26. Global Devices for Inhaled Medications Market Share by Price Range (2015-2020)
Figure 27. Global Devices for Inhaled Medications Sales Market Share by Application (2015-2020)
Figure 28. Global Devices for Inhaled Medications Sales Market Share by Application in 2019
Figure 29. Global Devices for Inhaled Medications Revenue Market Share by Application (2015-2020)
Figure 30. Global Devices for Inhaled Medications Revenue Market Share by Application in 2019
Figure 31. United States Devices for Inhaled Medications Sales Growth

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs